https://www.clinicaltrialsarena.com/comment/barriers-impede-biosimilar-market-entry-us/
Barriers impede biosimilar market entry into the US - Clinical Trials Arena
May 8, 2018 - Back in 2010, the FDA implemented the Biologics Price Competition and Innovation Act (BPCIA) as part of the Affordable Care Act (ACA), which created an...
us clinical trialsmarket entrybarriersimpedebiosimilar
https://www.firmenpresse.de/pressrelease18357/clinuvel-pharmaceuticals-ltd-fda-allows-us-clinical-trials-of-afamelanotide-in-epp-br.html
Clinuvel Pharmaceuticals Ltd.: FDA allows US clinical trials of afamelanotide in EPP
Clinuvel Pharmaceuticals Ltd.: FDA allows US clinical trials of afamelanotide in EPPPhase II trial of novel drug in erythropoietic protoporphyri ...
us clinical trials